Pagina inicial
Continue Watching
Últimos vídeos
Últimos vídeos
Brightcove Home Latest Listing
Oncology
Oncology
Brightcove Cards Listing
Hematology
Hematology
Brightcove Cards Listing
Popular em MedEnrich
Popular em MedEnrich
Popular in Sem nome
Critical Care18m 47s
Antimicrobial stewardship: Discutir a importância do uso responsável de antimicrobianos
Antimicrobial stewardship: Discutir a importância do uso responsável de antimicrobianos para prevenir a resistência bacteriana e melhorar os resultados do tratamento
infecções hospitalares
hospitalar
daptomicina
resistência à vancomicina
terapia antimicrobiana
1
Antimicrobial stewardship: Discutir a importância...
Mieloma múltiplo10m 40s
Recommendations -Management of Myeloma Related Renal Impairment
Supportive Care, Mechanical Approach and Systemic Antimyeloma treatment are 3 pillars of management of Myeloma related renal impairment. In supportive care prompt initiation of high fluid administration, appropriate use of Bisphosphonates can help.
myeloma
renal impairment
lancet guidelines
1
Recommendations -Management of Myeloma Related...
Myelodysplastic Syndromes3m 14s
Low Risk MDS - Key Practice Points
Myelodysplastic Syndromes (MDS) or Myeloproliferative Neoplasms show considerable heterogeneity with respect to presence of anemia , cytopenia & molecular features.
ipss -m
low risk
molecular features
1
Low Risk MDS - Key Practice Points
11m 28s
ESR1 Mutation in Hormone Receptor Positive Advanced Breast Cancer
ESR1 mutation leads to ligand independent activation of estrogen receptor. ESR1 mutations were first described in 1997 & their role remain underestimated as initial research was focused on primary tumor wherein these mutations were absent.
aromatase inhibitor resistance
hr +ve mbc
esr1 mutation
fulvestrant
1
ESR1 Mutation in Hormone Receptor Positive Advanced...
11m 28s
ESR1 Mutation in Hormone Receptor Positive Advanced Breast Cancer
ESR1 mutation leads to ligand independent activation of estrogen receptor. ESR1 mutations were first described in 1997 & their role remain underestimated as initial research was focused on primary tumor wherein these mutations were absent.
aromatase inhibitor resistance
hr +ve mbc
esr1 mutation
fulvestrant
1
ESR1 Mutation in Hormone Receptor Positive Advanced...
3m 36s
Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer
Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
tumor-infiltrating lymphocytes (tils)
promising biomarker
1
Tumor Infiltrating Lymphocytes as Predictive...
3m 36s
Tumor Infiltrating Lymphocytes as Predictive Biomarker in Breast Cancer
Immune cells known as tumor-infiltrating lymphocytes (TILs) are thought to be a promising, affordable biomarker with prognostic and predictive potential.
tumor-infiltrating lymphocytes (tils)
promising biomarker
1
Tumor Infiltrating Lymphocytes as Predictive...
Myelodysplastic Syndromes4m 0s
Selecting Right Patients for Early Initiation in HMAs in Low Risk MDS
Selecting the right patients for early initiation of hypomethylating agents (HMAs) in low-risk MDS involves identifying those with progressive cytopenias, poor prognostic mutations, or high-risk features despite low-risk classification.
hypomethylating agents (hmas)
disease progression
personalised treatment plans
low risk mds
1
Selecting Right Patients for Early Initiation in...
Transplant15m 53s
Profilaxia de CMV em receptores de transplantes
Conheça as estratégias de profilaxia de CMV no pós-transplante de órgãos sólidos, melhor forma de manejo e monitorização de viremia.
cmv
hospitalar
valganciclovir
antiviral
manejo de viremia
transplante
1
Profilaxia de CMV em receptores de transplantes
Mieloma múltiplo13m 11s
Management of Infections in Multiple Myeloma
Risk of infections in multiple myeloma has increased with the use of Novel treatments like Proteosome inhibitors, CD38 targeting MABs & BCMA targeted drugs.
vaccination
myeloma
prophylaxis
infections
1